281 related articles for article (PubMed ID: 21732829)
1. Wnt signaling and Dupuytren's disease.
Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of WNT Signaling Pathway Gene Variants
Samulėnas G; Smalinskienė A; Rimdeika R; Braziulis K; Fomkinas M; Paškevičius R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573275
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling and Dupuytren's disease.
Balaji KN; Kaveri SV; Bayry J
N Engl J Med; 2011 Nov; 365(18):1740; author reply 1740. PubMed ID: 22047569
[No Abstract] [Full Text] [Related]
4. WNT2 locus is involved in genetic susceptibility of Peyronie's disease.
Dolmans GH; Werker PM; de Jong IJ; Nijman RJ; ; Wijmenga C; Ophoff RA
J Sex Med; 2012 May; 9(5):1430-4. PubMed ID: 22489561
[TBL] [Abstract][Full Text] [Related]
5. SNPs previously associated with Dupuytren's disease replicated in a North American cohort.
Anderson ER; Ye Z; Caldwell MD; Burmester JK
Clin Med Res; 2014 Dec; 12(3-4):133-7. PubMed ID: 24573701
[TBL] [Abstract][Full Text] [Related]
6. Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.
Ten Dam EJ; van Beuge MM; Bank RA; Werker PM
J Cell Commun Signal; 2016 Mar; 10(1):33-40. PubMed ID: 26635199
[TBL] [Abstract][Full Text] [Related]
7. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
Becker K; Siegert S; Toliat MR; Du J; Casper R; Dolmans GH; Werker PM; Tinschert S; Franke A; Gieger C; Strauch K; Nothnagel M; Nürnberg P; Hennies HC;
PLoS One; 2016; 11(7):e0158101. PubMed ID: 27467239
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease.
Riesmeijer SA; Kamali Z; Ng M; Drichel D; Piersma B; Becker K; Layton TB; Nanchahal J; Nothnagel M; Vaez A; Hennies HC; Werker PMN; Furniss D; Nolte IM
Nat Commun; 2024 Jan; 15(1):199. PubMed ID: 38172110
[TBL] [Abstract][Full Text] [Related]
11. Common variants of the EPDR1 gene and the risk of Dupuytren’s disease.
Dębniak T; Żyluk A; Puchalski P; Serrano-Fernandez P
Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):253-7. PubMed ID: 24089297
[TBL] [Abstract][Full Text] [Related]
12. DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.
Shih B; Tassabehji M; Watson JS; Bayat A
Plast Reconstr Surg; 2012 Apr; 129(4):921-932. PubMed ID: 22183494
[TBL] [Abstract][Full Text] [Related]
13. Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From Neandertals.
Ågren R; Patil S; Zhou X; ; Sahlholm K; Pääbo S; Zeberg H
Mol Biol Evol; 2023 Jun; 40(6):. PubMed ID: 37315093
[TBL] [Abstract][Full Text] [Related]
14. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.
Mosakhani N; Guled M; Lahti L; Borze I; Forsman M; Pääkkönen V; Ryhänen J; Knuutila S
Mod Pathol; 2010 Nov; 23(11):1544-52. PubMed ID: 20676061
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.
Bayat A; Alansar A; Hajeer AH; Shah M; Watson JS; Stanley JK; Ferguson MW; Ollier WE
J Hand Surg Br; 2002 Feb; 27(1):47-9. PubMed ID: 11895345
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.
Major M; Freund MK; Burch KS; Mancuso N; Ng M; Furniss D; Pasaniuc B; Ophoff RA
Genet Epidemiol; 2019 Sep; 43(6):629-645. PubMed ID: 31087417
[TBL] [Abstract][Full Text] [Related]
17. Association of Morbus Ledderhose with Dupuytren's contracture.
Gudmundsson KG; Jónsson T; Arngrímsson R
Foot Ankle Int; 2013 Jun; 34(6):841-5. PubMed ID: 23386754
[TBL] [Abstract][Full Text] [Related]
18. A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren's Disease.
Riesmeijer SA; Manley OWG; Ng M; Nolte IM; Broekstra DC; Werker PMN; Furniss D
Plast Reconstr Surg; 2019 Feb; 143(2):512-518. PubMed ID: 30688894
[TBL] [Abstract][Full Text] [Related]
19. Sibling recurrence risk in Dupuytren's disease.
Capstick R; Bragg T; Giele H; Furniss D
J Hand Surg Eur Vol; 2013 May; 38(4):424-9. PubMed ID: 22791609
[TBL] [Abstract][Full Text] [Related]
20. The importance of genetic susceptibility in Dupuytren's disease.
Becker K; Tinschert S; Lienert A; Bleuler PE; Staub F; Meinel A; Rößler J; Wach W; Hoffmann R; Kühnel F; Damert HG; Nick HE; Spicher R; Lenze W; Langer M; Nürnberg P; Hennies HC
Clin Genet; 2015 May; 87(5):483-7. PubMed ID: 24749973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]